Sevelamer Hydrochloride Tablet, Film Coated
Product Images NDC 72162-2501

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sevelamer Hydrochloride (NDC 72162-2501). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl721622501)

This text provides information on Sevelamer Hydrochloride tablets containing 800 mg each. It includes details on the usual dosage, storage instructions, and manufacturer information. The tablets should be dispensed in a tight container and protected from moisture, with storage recommended at 20° to 25°C. Additional details on prescribing information and administration are available through scanning the package insert QR code.*

FDA Label Image

Figure-2 (Sevelamer Figure 2)

This data sheet presents information on the reduction in serum phosphorus levels of patients using Sevelamer Hydrochloride compared to an active control. The chart shows the percentage of patients with reduction greater than a certain threshold, along with the reduction from baseline in serum phosphorus levels. It indicates whether the change in levels worsened, remained the same, or improved. The data provides valuable insights into the effectiveness of Sevelamer Hydrochloride in managing serum phosphorus levels.*

FDA Label Image

Figure-3 (Sevelamer Figure 3)

This is a description of phosphorus change from baseline during a study week with Sevelamer Hydrochloride, an active-control treatment. The data points provided are 14, 18, 26, 30, 34, 38, 42, and 4.*

FDA Label Image

Figure-1 (Sevelamer Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.